டேவிட் போல்ஸ்கீ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from டேவிட் போல்ஸ்கீ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In டேவிட் போல்ஸ்கீ Today - Breaking & Trending Today

Gene-based blood test for melanoma spread evaluates treatment progress


 E-Mail
A test that monitors blood levels of DNA fragments released by dying tumor cells may serve as an accurate early indicator of treatment success in people in late stages of one of the most aggressive forms of skin cancer, a new study finds.
Led by NYU Grossman School of Medicine and Perlmutter Cancer Center researchers, the investigation looked at adults with undetectable levels of freely circulating tumor DNA (ctDNA) four weeks into drug treatment for metastatic melanoma tumors that cannot be removed surgically (unresectable). The study showed that these patients, all of whom had common genetic changes (BRAFV600 mutations) linked to cancer, were living nearly twice as long without cancer growth as those who continued to have detectable levels. ....

United States , France General , New South Wales , Western Australia , Baden Wuberg , University Of Texas , David Polsky , Jennifer Wiggins , Dirk Schadendorf , Los Angeles , Antoni Ribas , Mahrukh Syeda , Matthew Squires , Eduard Gasal , Caroline Robert , Paul Nathan , James Garrett , Alfredw Kopf , Jan Brase , Keith Flaherty , Michael Davies , Broderickc Corless , Jean Jacques Grob , University Of California , Langone Health , Novartis Institute For Biomedical Research In Cambridge ,

Gene-based blood test for melanoma spread evaluates treatment progress: Study


Gene-based blood test for melanoma spread evaluates treatment progress: Study
ANI |
Updated: Feb 13, 2021 12:51 IST
Washington [US], February 13 (ANI): A test that monitors blood levels of DNA fragments released by dying tumor cells may serve as an accurate early indicator of treatment success in people in the late stages of one of the most aggressive forms of skin cancer, a new study finds.
Led by NYU Grossman School of Medicine and Perlmutter Cancer Center researchers, the investigation looked at adults with undetectable levels of freely circulating tumor DNA (ctDNA) four weeks into drug treatment for metastatic melanoma tumors that cannot be removed surgically (unresectable). ....

United States , David Polsky , Mahrukh Syeda , Alfredw Kopf , Langone Health , Grossman School Of Medicine , Department Of Pathology , Department Of Dermatology , Perlmutter Cancer Center , Dermatologic Oncology , Perlmutter Cancer , Lancet Oncology , Gene Based Blood Test , Latest Health Related Study , ஒன்றுபட்டது மாநிலங்களில் , டேவிட் போல்ஸ்கீ , லன்கொனே ஆரோக்கியம் , மொத்த மனிதர் பள்ளி ஆஃப் மருந்து , துறை ஆஃப் நோயியல் , துறை ஆஃப் தோல் நோய் , பேர்ல்முத்தேர் புற்றுநோய் மையம் , தோல் நோய் புற்றுநோயியல் , பேர்ல்முத்தேர் புற்றுநோய் , கீந் அடிப்படையிலானது இரத்தம் சோதனை , சமீபத்தியது ஆரோக்கியம் தொடர்புடையது படிப்பு ,